Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
🔒 Full content requires a free HCP account. Register free or sign in.
CPD ACCREDITED

Clinical Education Hub

Diabetes / Metabolic education resources: CPD modules, podcasts and webinars for clinical learning.

6
Education Items
4
Podcasts & Webinars
CPD
Certificates Where Available
Specialty: AllCardiology / CardiovascularDermatologyDiabetes / MetabolicGastroenterologyHaematologyInfectious DiseaseMen's HealthMental Health / PsychiatryNephrologyNeurology
Webinar 0.5 CPD hrs
SGLT2 Inhibitors: From Glycaemia to Heart Failure and Chronic Kidney Disease
Diabetes / Metabolic

SGLT2 inhibitors started as diabetes drugs and became some of the most important medicines in cardiology and nephrology.…

📅 05 Apr 2026 Watch Webinar →
Webinar 0.5 CPD hrs
GLP-1 Agonists: Semaglutide, Tirzepatide and the Cardiovascular Revolution
Diabetes / Metabolic

GLP-1 agonists have transformed the treatment of type 2 diabetes and obesity. In this episode, Dr Anzal Qurbain…

📅 05 Apr 2026 Watch Webinar →
Podcast 00:15:32
GLP-1 Agonists: Semaglutide, Tirzepatide and the Cardiovascular Revolution
Diabetes / Metabolic

GLP-1 agonists have transformed the treatment of type 2 diabetes and obesity. In this episode, Dr Anzal Qurbain…

📅 03 Apr 2026 Listen →
Podcast 00:14:06
SGLT2 Inhibitors: From Glycaemia to Heart Failure and Chronic Kidney Disease
Diabetes / Metabolic

SGLT2 inhibitors started as diabetes drugs and became some of the most important medicines in cardiology and nephrology.…

📅 03 Apr 2026 Listen →
CPD Module Intermediate 1.5 CPD hrs
NICE NG28: Type 2 Diabetes in Adults — 2024 Update
Diabetes / Metabolic

CPD module on NICE NG28 type 2 diabetes updates, including SGLT2/GLP-1 therapy selection, HbA1c targets, renal and cardiovascular…

📅 25 Mar 2026 Start Module →
CPD Module Advanced 1.5 CPD hrs
Cardiovascular Risk Reduction — Latest Evidence 2024
Cardiology / Cardiovascular

Advanced CPD on cardiovascular risk reduction, covering QRISK3, statin intensification, ezetimibe, PCSK9 inhibitors, inclisiran and monitoring.

📅 25 Mar 2026 Start Module →